Inhibitors of arginase and their therapeutic applications

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9266908
APP PUB NO 20140343019A1
SERIAL NO

14352554

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The inventive compounds are small molecule therapeutics that are potent inhibitors of Arginase I and II activity. The invention also provides pharmaceutical compositions of the inventive compounds and methods for using the inventive compounds for treating or preventing a disease or a condition associated with arginase activity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MARS INCORPORATED6885 ELM STREET MCLEAN VA 22101-3883

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beckett, Raymond Paul McLean, US 42 254
Golebiowski, Adam McLean, US 31 164
Ji, Min Koo McLean, US 4 67
Ryder, Todd McLean, US 5 73
Van, Zandt Michael McLean, US 28 263
Whitehouse, Darren McLean, US 28 356

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 23, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00